Sponsor pipeline

Telios Pharma, Inc. clinical trial pipeline

Get alerts when Telios Pharma, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07220408 Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis Allergic Conjunctivitis Recruiting 2025-11-25
NCT06686472 Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis Allergic Conjunctivitis Recruiting 2024-11-13
Phase 1/2
NCT05280509 Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and… Myelofibrosis Recruiting 2023-02-21

Disease areas by active trials

Myelofibrosis (1)

Get alerts when Telios Pharma, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free